Skip to main content
logo
Cyclopharm Limited (ASX:CYC)
Australia flag Australia · Delayed Price · Currency is AUD
0.5350
-0.0350 (-6.14%)
Aug 11, 2026, 4:10 PM AEST

Cyclopharm Revenue

In the year 2025, Cyclopharm had annual revenue of 32.33M AUD with 17.24% growth. Cyclopharm had revenue of 16.90M in the half year ending December 31, 2025, with 68.21% growth.

Revenue
32.33M
Revenue Growth
+17.24%
P/S Ratio
2.22
Revenue / Employee
296.56K
Employees
109
Market Cap
71.86M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.33M4.75M17.24%
Dec 31, 202427.57M1.23M4.68%
Dec 31, 202326.34M1.48M5.97%
Dec 31, 202224.85M4.86M24.30%
Dec 31, 202120.00M2.31M13.09%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
SomnoMed118.50M
Saluda Medical114.04M
Compumedics58.49M
Nova Eye Medical33.05M
CleanSpace Holdings20.66M
Lumos Diagnostics Holdings18.31M
EMVision Medical Devices5.43M
OncoSil Medical3.72M
Revenue Rankings

Cyclopharm News

More News